About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Pulmonary Sarcoidosis Concurrent with Lupus Pernio and Peri-aortitis
Kyawzaw Lin1, Sithu Lin1, Aung Naing Lin1, Thinzar Lin1, Louis Gerolemou2, Ameer Rasheed2
Departments of 1Internal Medicine and 2Pulmonology, The Brooklyn Hospital Center, Affiliate of the Mount Sinai Hospital, 
121, Dekalb Avenue, Brooklyn, NY 11201.
Corresponding Author:
Dr. Kyawzaw Lin
Email: dr.kyawzawlin2015@gmail.com
Received: 19-AUG-2017 Accepted: 15-OCT-2017 Published Online: 30-OCT-2017
DOI: http://dx.doi.org/10.17659/01.2017.0095
Abstract
Background: In the literature, the concurrence of pulmonary sarcoidosis in association with lupus pernio and peri-aortitis is extremely rare and has poor prognosis. The time lag between the diagnosis of sarcoidosis and aortitis varies from 6 months to 20 years. However, aortitis was diagnosed before sarcoidosis in a few cases. Case Report: We present a 49-year-male with stage 4 pulmonary sarcoidosis and lupus pernio who presented with frequent exacerbation of asthma. Recent pulmonary function test revealed very severe mixed obstruction and restriction with predicted FEV1 21% and DLCO 52%. Chest X-ray showed diffuse bilateral lung fibrosis (stage 4 pulmonary sarcoidosis). CT scan (chest) showed widespread ground-glass attenuation with reticulo-nodular areas in both lungs and dilatation of thoracic aorta. Magnetic resonance angiography (MRA) revealed aortitis. Conclusion: Despite rarity, lupus pernio (LP) can be preceding sign of intra-thoracic involvement of sarcoidosis. In a few, peri-aortitis can be succeeding complication or concurrence of sarcoidosis. Corticosteroid or immunosuppressant is mainstay of treatment.
Keywords : Aortitis, Asthma, Dilatation, Lung, Respiratory Function Tests, Sarcoidosis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024